摘要
目的观察分析类风湿关节炎采用美洛昔康、来氟米特联合活血化瘀法的临床治疗效。方法选取106例类风湿关节炎患者,随机状态下分为西药治疗组和中西联合治疗组,对两组患者采用不同治疗方法,西药治疗组给予美洛昔康、来氟米特治疗,中西联合治疗组在西药治疗的基础上增加活血化瘀治疗法,对比和观察两组治疗效果。结果西药治疗组有效率83.4%,中西联合治疗组有效率94.6%,治疗后CRP、ESR等指标改善,两组临床治疗效果对比,差异有统计学意义(P<0.05)。结论类风湿关节炎采用中西联合治疗的临床疗效优于单纯采用美洛昔康、来氟米特治疗的临床疗效。
Objective To observe the effects of analysis of rheumatoid arthritis by meloxicam, leflunomide combined with Huoxuehuayu method of effect of clinical cure. Methods Select 106 cases of rheumatoid arthritis patients and random state points for the group treated by western medicine and traditional Chinese medicine combined with Western treatment group, of two groups of patients with different treatment methods, western medicine treatment group given meloxicam, leflunomide therapy, combined therapy of Chinese and western group increased promoting blood circulation and removing blood stasis method on the basis of Western medicine treatment, comparison and observation of the therapeutic effect of two groups. Results Western medicine treatment group effective rate 83.4%, Chinese and Western combined treatment group effective rate of 94.6%, after treatment, ESR, CRP and other indicators improved, two groups of clinical treatment effect comparison, the difference was statistically significant （P 〈0.05）. Conclusion Rheumatoid arthritis with the clinical efficacy of traditional Chinese medicine combined with Western treatment is better than simple use of meloxicam Kang, the clinical curative effect of leflunomide in the treatment.
出处
《中国继续医学教育》
2016年第20期181-182,共2页
China Continuing Medical Education
